Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Silverstone, PH; Salinas, E
   Efficacy of venlafaxine extended release in patients with major depressivedisorder and comorbid generalized anxiety disorder
   JOURNAL OF CLINICAL PSYCHIATRY
   
   P.H. Silverstone e E. Salinas, "Efficacy of venlafaxine extended release in patients with major depressivedisorder and comorbid generalized anxiety disorder", J CLIN PSY, 62(7), 2001, pp. 523-529
2. Silverstone, PH; Birkett, L
   Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: a retrospective study
   JOURNAL OF PSYCHIATRY & NEUROSCIENCE
   
   P.H. Silverstone e L. Birkett, "Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: a retrospective study", J PSYCH NEU, 25(3), 2000, pp. 276-280
3. O'Donnell, T; Rotzinger, S; Nakashima, TT; Hanstock, CC; Ulrich, M; Silverstone, PH
   Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in ratbrain
   BRAIN RESEARCH
   
   T. O'Donnell et al., "Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in ratbrain", BRAIN RES, 880(1-2), 2000, pp. 84-91
4. Silverstone, PH; Hanstock, CC; Rotzinger, S
   Lithium does not alter the choline creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy
   JOURNAL OF PSYCHIATRY & NEUROSCIENCE
   
   P.H. Silverstone et al., "Lithium does not alter the choline creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy", J PSYCH NEU, 24(3), 1999, pp. 222-226
5. Silverstone, PH
   Neuroimaging and the psychiatry of late life.
   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
   
   P.H. Silverstone, "Neuroimaging and the psychiatry of late life.", CAN J PSY, 44(7), 1999, pp. 706-707
6. de Montigny, C; Silverstone, PH; Debonnel, G; Blier, P; Bakish, D
   Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   C. de Montigny et al., "Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial", J CL PSYCH, 19(5), 1999, pp. 401-406
7. Silverstone, PH; Ravindran, A
   Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety - Drs. Silverstone and Ravindran reply
   JOURNAL OF CLINICAL PSYCHIATRY
   
   P.H. Silverstone e A. Ravindran, "Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety - Drs. Silverstone and Ravindran reply", J CLIN PSY, 60(11), 1999, pp. 796-796
8. Silverstone, PH; Ravindran, A
   Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety
   JOURNAL OF CLINICAL PSYCHIATRY
   
   P.H. Silverstone e A. Ravindran, "Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety", J CLIN PSY, 60(1), 1999, pp. 22-28
9. Silverstone, PH; Rotzinger, S; Pukhovsky, A; Hanstock, CC
   Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by H-1 and P-31 MRS
   BIOLOGICAL PSYCHIATRY
   
   P.H. Silverstone et al., "Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by H-1 and P-31 MRS", BIOL PSYCHI, 46(12), 1999, pp. 1634-1641
10. SILVERSTONE PH
    PREVENTION OF CLOZAPINE-INDUCED NEUTROPENIA BY PRETREATMENT WITH LITHIUM
    Journal of clinical psychopharmacology
    
    P.H. Silverstone, "PREVENTION OF CLOZAPINE-INDUCED NEUTROPENIA BY PRETREATMENT WITH LITHIUM", Journal of clinical psychopharmacology, 18(1), 1998, pp. 86-88
11. SILVERSTONE PH; PUKHOVSKY A; ROTZINGER S
    LITHIUM DOES NOT ATTENUATE THE EFFECTS OF D-AMPHETAMINE IN HEALTHY-VOLUNTEERS
    Psychiatry research
    
    P.H. Silverstone et al., "LITHIUM DOES NOT ATTENUATE THE EFFECTS OF D-AMPHETAMINE IN HEALTHY-VOLUNTEERS", Psychiatry research, 79(3), 1998, pp. 219-226
12. URICHUK LJ; ASPESLET LJ; HOLT A; SILVERSTONE PH; COUTTS RT; BAKER GB
    DETERMINATION OF P-TRIFLUOROMETHYLPHENOL, A METABOLITE OF FLUOXETINE,IN TISSUES AND BODY-FLUIDS USING AN ELECTRON-CAPTURE GAS-CHROMATOGRAPHIC PROCEDURE
    Journal of chromatography B. Biomedical sciences and applications
    
    L.J. Urichuk et al., "DETERMINATION OF P-TRIFLUOROMETHYLPHENOL, A METABOLITE OF FLUOXETINE,IN TISSUES AND BODY-FLUIDS USING AN ELECTRON-CAPTURE GAS-CHROMATOGRAPHIC PROCEDURE", Journal of chromatography B. Biomedical sciences and applications, 698(1-2), 1997, pp. 103-109
13. TIBBO P; SILVERSTONE PH; MCEWAN AJB; SCOTT J; JOSHUA A; GOLBERG K
    A SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY SCAN STUDY OF STRIATAL DOPAMINE D-2 RECEPTOR-BINDING WITH I-123 EPIDEPRIDE IN PATIENTS WITH SCHIZOPHRENIA AND CONTROLS
    Journal of psychiatry & neuroscience
    
    P. Tibbo et al., "A SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY SCAN STUDY OF STRIATAL DOPAMINE D-2 RECEPTOR-BINDING WITH I-123 EPIDEPRIDE IN PATIENTS WITH SCHIZOPHRENIA AND CONTROLS", Journal of psychiatry & neuroscience, 22(1), 1997, pp. 39-45
14. SILVERSTONE PH
    CURRENT PSYCHOTHERAPEUTIC DRUGS - KLEIN,DF
    Canadian journal of psychiatry
    
    P.H. Silverstone, "CURRENT PSYCHOTHERAPEUTIC DRUGS - KLEIN,DF", Canadian journal of psychiatry, 42(9), 1997, pp. 975-975
15. KUSUMAKAR V; YATHAM LN; HASLAM DRS; PARIKH SV; MATTE R; SILVERSTONE PH; SHARMA V
    TREATMENT OF MANIA, MIXED-STATE, AND RAPID-CYCLING
    Canadian journal of psychiatry
    
    V. Kusumakar et al., "TREATMENT OF MANIA, MIXED-STATE, AND RAPID-CYCLING", Canadian journal of psychiatry, 42, 1997, pp. 79-86
16. SHARMA V; YATHAM LN; HASLAM DRS; SILVERSTONE PH; PARIKH SV; MATTE R; KUTCHER SP; KUSUMAKAR V
    CONTINUATION AND PROPHYLACTIC TREATMENT OF BIPOLAR DISORDER
    Canadian journal of psychiatry
    
    V. Sharma et al., "CONTINUATION AND PROPHYLACTIC TREATMENT OF BIPOLAR DISORDER", Canadian journal of psychiatry, 42, 1997, pp. 92-100
17. FANG J; BAKER GB; SILVERSTONE PH; COUTTS RT
    INVOLVEMENT OF CYP3A4 AND CYP2D6 IN THE METABOLISM OF HALOPERIDOL
    Cellular and molecular neurobiology
    
    J. Fang et al., "INVOLVEMENT OF CYP3A4 AND CYP2D6 IN THE METABOLISM OF HALOPERIDOL", Cellular and molecular neurobiology, 17(2), 1997, pp. 227-233
18. FABIAN JE; SILVERSTONE PH
    DILTIAZEM, A CALCIUM-ANTAGONIST, PARTLY ATTENUATES THE EFFECTS OF DEXTROAMPHETAMINE IN HEALTHY-VOLUNTEERS
    International clinical psychopharmacology
    
    J.E. Fabian e P.H. Silverstone, "DILTIAZEM, A CALCIUM-ANTAGONIST, PARTLY ATTENUATES THE EFFECTS OF DEXTROAMPHETAMINE IN HEALTHY-VOLUNTEERS", International clinical psychopharmacology, 12(2), 1997, pp. 113-120
19. GREENSHAW AJ; SILVERSTONE PH
    THE NON-ANTIEMETIC USES OF SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS - CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS
    Drugs
    
    A.J. Greenshaw e P.H. Silverstone, "THE NON-ANTIEMETIC USES OF SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS - CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS", Drugs, 53(1), 1997, pp. 20-39
20. SILVERSTONE PH; GREENSHAW AJ
    5-HT3 RECEPTOR ANTAGONISTS
    Expert opinion on therapeutic patents
    
    P.H. Silverstone e A.J. Greenshaw, "5-HT3 RECEPTOR ANTAGONISTS", Expert opinion on therapeutic patents, 6(5), 1996, pp. 471-481
21. SILVERSTONE PH; LEMAY T; ELLIOTT J; HSU V; STARKO R
    THE PREVALENCE OF MAJOR DEPRESSIVE DISORDER AND LOW SELF-ESTEEM IN MEDICAL INPATIENTS
    Canadian journal of psychiatry
    
    P.H. Silverstone et al., "THE PREVALENCE OF MAJOR DEPRESSIVE DISORDER AND LOW SELF-ESTEEM IN MEDICAL INPATIENTS", Canadian journal of psychiatry, 41(2), 1996, pp. 67-74
22. SILVERSTONE PH
    CONCISE ASSESSMENT FOR DEPRESSION (CAD) - A BRIEF SCREENING APPROACH TO DEPRESSION IN THE MEDICALLY ILL
    Journal of psychosomatic research
    
    P.H. Silverstone, "CONCISE ASSESSMENT FOR DEPRESSION (CAD) - A BRIEF SCREENING APPROACH TO DEPRESSION IN THE MEDICALLY ILL", Journal of psychosomatic research, 41(2), 1996, pp. 161-170
23. SILVERSTONE PH
    PREVALENCE OF PSYCHIATRIC-DISORDERS IN MEDICAL INPATIENTS
    The Journal of nervous and mental disease
    
    P.H. Silverstone, "PREVALENCE OF PSYCHIATRIC-DISORDERS IN MEDICAL INPATIENTS", The Journal of nervous and mental disease, 184(1), 1996, pp. 43-51
24. SILVERSTONE PH; HANSTOCK CC; FABIAN J; STAAB R; ALLEN PS
    CHRONIC LITHIUM DOES NOT ALTER HUMAN MYOINOSITOL OR PHOSPHOMONOESTER CONCENTRATIONS AS MEASURED BY H-1 AND P-31 MRS
    Biological psychiatry
    
    P.H. Silverstone et al., "CHRONIC LITHIUM DOES NOT ALTER HUMAN MYOINOSITOL OR PHOSPHOMONOESTER CONCENTRATIONS AS MEASURED BY H-1 AND P-31 MRS", Biological psychiatry, 40(4), 1996, pp. 235-246
25. SILVERSTONE PH; RUE JE; FRANKLIN M; HALLIS K; CAMPLIN G; LAVER D; COWEN PJ
    THE EFFECTS OF ADMINISTRATION OF MCPP ON PSYCHOLOGICAL, COGNITIVE, CARDIOVASCULAR, HORMONAL AND MHPG MEASUREMENTS IN HUMAN VOLUNTEERS
    International clinical psychopharmacology
    
    P.H. Silverstone et al., "THE EFFECTS OF ADMINISTRATION OF MCPP ON PSYCHOLOGICAL, COGNITIVE, CARDIOVASCULAR, HORMONAL AND MHPG MEASUREMENTS IN HUMAN VOLUNTEERS", International clinical psychopharmacology, 9(3), 1994, pp. 173-178
26. SILVERSTONE PH
    POOR EFFICACY OF THE HOSPITAL ANXIETY AND DEPRESSION SCALE IN THE DIAGNOSIS OF MAJOR DEPRESSIVE DISORDER IN BOTH MEDICAL AND PSYCHIATRIC-PATIENTS
    Journal of psychosomatic research
    
    P.H. Silverstone, "POOR EFFICACY OF THE HOSPITAL ANXIETY AND DEPRESSION SCALE IN THE DIAGNOSIS OF MAJOR DEPRESSIVE DISORDER IN BOTH MEDICAL AND PSYCHIATRIC-PATIENTS", Journal of psychosomatic research, 38(5), 1994, pp. 441-450
27. SILVERSTONE PH; COWEN PJ
    THE 5-HT3 ANTAGONIST, BRL-46470 DOES NOT ATTENUATE M-CHLOROPHENYLPIPERAZINE (MCPP)-INDUCED CHANGES IN HUMAN VOLUNTEERS
    Biological psychiatry
    
    P.H. Silverstone e P.J. Cowen, "THE 5-HT3 ANTAGONIST, BRL-46470 DOES NOT ATTENUATE M-CHLOROPHENYLPIPERAZINE (MCPP)-INDUCED CHANGES IN HUMAN VOLUNTEERS", Biological psychiatry, 36(5), 1994, pp. 309-316
28. SILVERSTONE PH
    SCAN ACCURATELY GIVES DIAGNOSES ACCORDING TO DSM-III-R CRITERIA - VALIDATION IN PSYCHIATRIC-PATIENTS USING SADS
    International journal of methods in psychiatric research
    
    P.H. Silverstone, "SCAN ACCURATELY GIVES DIAGNOSES ACCORDING TO DSM-III-R CRITERIA - VALIDATION IN PSYCHIATRIC-PATIENTS USING SADS", International journal of methods in psychiatric research, 3(4), 1993, pp. 209-213
29. SILVERSTONE PH; DONE C; SHARP T
    IN-VIVO MONOAMINE RELEASE DURING NALOXONE-PRECIPITATED MORPHINE-WITHDRAWAL
    NeuroReport
    
    P.H. Silverstone et al., "IN-VIVO MONOAMINE RELEASE DURING NALOXONE-PRECIPITATED MORPHINE-WITHDRAWAL", NeuroReport, 4(8), 1993, pp. 1043-1045